公司资料
NRX Pharmaceuticals, Inc. 股价、新闻与催化剂
- 股票代码:
- NRXP
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
3.45 USD (-3.09%)
收盘价
最后更新: 2026年8月24日
167M USD
市值
股价为何变动
As of Aug 24, 2026, NRXP closed down 3.09% at $3.45. No new same-company headline was identified in the current news window.
公司概览
业务概览
NRX Pharmaceuticals is a neuroscience and psychiatric-care company focused on severe depression and related central nervous system conditions. Its story has centered on hard-to-treat mental-health disorders.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, NRX sits in specialty biotechnology.
商业模式特征
The company depends on clinical progress, regulatory steps, and the ability to create value in CNS medicine.
生物医药行业定位
NRX is a high-risk CNS name whose valuation is driven by clinical and strategic developments.
未来催化剂
- NRX Pharmaceuticals’s catalysts are NRX-100 / NRX-101 and the CNS / ketamine-related development path, plus any strategic or regulatory update. The company still needs a clean execution step.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。